|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print November 20, 2008 J. Lipid Res., doi:10.1194/jlr.R800081-JLR200
Genomic & Molecular Medicine, MRC Clinical Sciences Centre, London W12 0NN
Corresponding Author: carol.shoulders{at}csc.mrc.ac.uk
This review summarises the progress made in cutting through the biological and genetic complexity of the Gordian-knot that is Familial Combined Hyperlipidemia. We particularly focus on how the application of new genomic technologies, especially massively parallel sequencing and high-throughput genotyping platforms, promise to accelerate the gene discovery process in this common, highly atherogenic disorder, with important diagnostic and therapeutic implications.
Related Webpages:
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||